Bridging the GAP in Liquid Biopsies — CTCs & cfDNA: A Comprehensive Approach to Detection & Monitoring of Cancer

Time: 10:45 am
day: Day One


• Cancer is a high complexity disease which requires a combination of biological insights from both genotypic and phenotypic analysis to guide precision medicine
• Circulating tumor cells (CTCs) and cell free DNA (cfDNA) liquid biopsies enable complementary information for clinical decisions, allowing for diagnosis, accurate prognosis, therapeutic target selection, as well as monitoring response and resistance to treatment
• Find out how these technologies enable a true Comprehensive Cancer Profiling from a single tube of blood to get all the biological insights needed